These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12649189)

  • 41. Variations in antigen-antibody association kinetics as a function of pH and salt concentration: a QSAR and molecular modeling study.
    Dejaegere A; Choulier L; Lafont V; De Genst E; Altschuh D
    Biochemistry; 2005 Nov; 44(44):14409-18. PubMed ID: 16262241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance.
    Kikuchi Y; Uno S; Nanami M; Yoshimura Y; Iida S; Fukushima N; Tsuchiya M
    J Biosci Bioeng; 2005 Sep; 100(3):311-7. PubMed ID: 16243282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids.
    Ackerman ME; Pawlowski D; Wittrup KD
    Mol Cancer Ther; 2008 Jul; 7(7):2233-40. PubMed ID: 18645032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In situ tumor ablation creates an antigen source for the generation of antitumor immunity.
    den Brok MH; Sutmuller RP; van der Voort R; Bennink EJ; Figdor CG; Ruers TJ; Adema GJ
    Cancer Res; 2004 Jun; 64(11):4024-9. PubMed ID: 15173017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.
    Schmidt MM; Thurber GM; Wittrup KD
    Cancer Immunol Immunother; 2008 Dec; 57(12):1879-90. PubMed ID: 18408925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.
    Jain RK
    Cancer Res; 1990 Feb; 50(3 Suppl):814s-819s. PubMed ID: 2404582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors.
    Beckman RA; Weiner LM; Davis HM
    Cancer; 2007 Jan; 109(2):170-9. PubMed ID: 17154393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.
    Wang J; Abbas Rizvi SM; Madigan MC; Cozzi PJ; Power CA; Qu CF; Morgenstern A; Apostolidis C; Russell PJ; Allen BJ; Li Y
    Prostate; 2006 Dec; 66(16):1753-67. PubMed ID: 16955401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The properties of immune complex-forming systems. A new theoretical approach.
    Steensgaard J; Liu BM; Cline GB; Møller NP
    Immunology; 1977 Apr; 32(4):445-56. PubMed ID: 608678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of charge on antibody tissue distribution and pharmacokinetics.
    Boswell CA; Tesar DB; Mukhyala K; Theil FP; Fielder PJ; Khawli LA
    Bioconjug Chem; 2010 Dec; 21(12):2153-63. PubMed ID: 21053952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.
    Lv Y; Cheung NK; Fu BM
    J Nucl Med; 2009 Aug; 50(8):1324-31. PubMed ID: 19617331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of rate constants of antigen-antibody reaction. A theory].
    Bobrovnik SA; Starodub NF
    Biokhimiia; 1988 May; 53(5):826-31. PubMed ID: 3167124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theoretical analysis of the Farr antibody assay with a computer model: importance of antigen concentration and antibody affinity.
    Griswold WR; Nelson DP
    J Immunoassay; 1984; 5(1-2):71-86. PubMed ID: 6715552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attractor control of the binding of digoxin to a specific antibody.
    Havsteen B
    J Theor Biol; 1997 Dec; 189(4):367-76. PubMed ID: 9446746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.